» Articles » PMID: 27480879

The Utility of T-wave Alternans During the Morning in the Summer for the Risk Stratification of Patients with Brugada Syndrome

Overview
Journal Heart Vessels
Date 2016 Aug 3
PMID 27480879
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The prognostic value of the seasonal variations of T-wave alternans (TWA) and heart rate variability (HRV), and the seasonal distribution of ventricular fibrillation (VF) in Brugada syndrome (Br-S) is unknown. We assessed the utility of seasonal variations in TWA and HRV for risk stratification in Br-S using a 24-h multichannel Holter electrocardiogram (24-M-ECG). We enrolled 81 patients with Br-S (grouped according to their history of VF, n = 12; syncope, n = 8; no symptoms, n = 61) who underwent 24-M-ECG in all four seasons. Precordial electrodes were attached to the third (3L-V2) and fourth (4L-V2, 4L-V5) intercostal spaces. We determined the maximum TWA (max-TWA) values and calculated HRV during night and morning time periods for all seasons. During a follow-up period of 5.8 ± 2.8 years, 11 patients experienced new VF episodes and there was a peak in new VF episodes in the summer. The VF group had the greatest 3L-V2 max-TWA value during morning time in the summer among the three groups and showed higher 3L-V2 max-TWA value than in the other seasons. The cutoff value for the 3L-V2 max-TWA during morning time in the summer was determined to be 42 µV using ROC analysis (82 % sensitivity, 74 % specificity; p = 0.0006). Multivariate analysis revealed that a 3L-V2 max-TWA value ≥42 µV during morning time in the summer and previous VF episodes were predictors of future VF episodes. The 3L-V2 max-TWA value during morning time in the summer may be a useful predictor of future VF episodes in Br-S.

Citing Articles

JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.

Takase B, Ikeda T, Shimizu W, Abe H, Aiba T, Chinushi M J Arrhythm. 2024; 40(4):655-752.

PMID: 39139890 PMC: 11317726. DOI: 10.1002/joa3.13052.


Standard ECG in Brugada Syndrome as a Marker of Prognosis: From Risk Stratification to Pathophysiological Insights.

Vitali F, Brieda A, Balla C, Pavasini R, Tonet E, Serenelli M J Am Heart Assoc. 2021; 10(10):e020767.

PMID: 33977759 PMC: 8200706. DOI: 10.1161/JAHA.121.020767.


Evaluation of the pulmonary artery potential using a 20-polar circumferential catheter and three-dimensional integrated intracardiac echocardiography.

Takahashi M, Yokoshiki H, Mitsuyama H, Tenma T, Watanabe M, Kamada R Heart Vessels. 2018; 34(1):74-83.

PMID: 29931540 DOI: 10.1007/s00380-018-1209-2.


Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.

Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Okamura H Heart Vessels. 2017; 32(10):1277-1283.

PMID: 28523371 DOI: 10.1007/s00380-017-0994-3.


Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.

Kakihara J, Takagi M, Hayashi Y, Tatsumi H, Doi A, Yoshiyama M Heart Vessels. 2017; 32(9):1151-1159.

PMID: 28364267 DOI: 10.1007/s00380-017-0973-8.

References
1.
Kirchhof P, Eckardt L, Rolf S, Esperer H, Paul M, Wichter T . T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome. Ann Noninvasive Electrocardiol. 2004; 9(2):162-5. PMC: 6932700. DOI: 10.1111/j.1542-474X.2004.92541.x. View

2.
Nakano Y, Shimizu W, Ogi H, Suenari K, Oda N, Makita Y . A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome. Europace. 2010; 12(3):410-6. DOI: 10.1093/europace/eup446. View

3.
Delise P, Allocca G, Marras E, Giustetto C, Gaita F, Sciarra L . Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J. 2010; 32(2):169-76. PMC: 3021386. DOI: 10.1093/eurheartj/ehq381. View

4.
Takigawa M, Noda T, Shimizu W, Miyamoto K, Okamura H, Satomi K . Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm. 2008; 5(11):1523-7. DOI: 10.1016/j.hrthm.2008.08.022. View

5.
. Guidelines for risks and prevention of sudden cardiac death (JCS 2010): – digest version –. Circ J. 2012; 76(2):489-507. DOI: 10.1253/circj.cj-88-0022. View